CN1766625A - 检测阿维菌素类药物的酶联免疫试剂盒及方法 - Google Patents
检测阿维菌素类药物的酶联免疫试剂盒及方法 Download PDFInfo
- Publication number
- CN1766625A CN1766625A CNA2005100867703A CN200510086770A CN1766625A CN 1766625 A CN1766625 A CN 1766625A CN A2005100867703 A CNA2005100867703 A CN A2005100867703A CN 200510086770 A CN200510086770 A CN 200510086770A CN 1766625 A CN1766625 A CN 1766625A
- Authority
- CN
- China
- Prior art keywords
- liquid
- kit
- solution
- avermectins medicine
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000005660 Abamectin Substances 0.000 title claims abstract description 68
- 238000001514 detection method Methods 0.000 title description 10
- 238000008157 ELISA kit Methods 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 61
- 239000007788 liquid Substances 0.000 claims abstract description 51
- 238000000034 method Methods 0.000 claims abstract description 35
- 239000000243 solution Substances 0.000 claims abstract description 20
- 102000004190 Enzymes Human genes 0.000 claims abstract description 19
- 108090000790 Enzymes Proteins 0.000 claims abstract description 19
- 239000000427 antigen Substances 0.000 claims abstract description 17
- 102000036639 antigens Human genes 0.000 claims abstract description 17
- 108091007433 antigens Proteins 0.000 claims abstract description 17
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 claims abstract description 14
- 239000012086 standard solution Substances 0.000 claims abstract description 14
- 238000004140 cleaning Methods 0.000 claims abstract description 7
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 claims description 26
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 claims description 26
- 229960002418 ivermectin Drugs 0.000 claims description 26
- 241001494479 Pecora Species 0.000 claims description 20
- 238000012360 testing method Methods 0.000 claims description 19
- 239000000758 substrate Substances 0.000 claims description 15
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 14
- 238000002965 ELISA Methods 0.000 claims description 13
- 239000000872 buffer Substances 0.000 claims description 11
- 239000012895 dilution Substances 0.000 claims description 11
- 238000010790 dilution Methods 0.000 claims description 11
- 230000001900 immune effect Effects 0.000 claims description 11
- 239000008363 phosphate buffer Substances 0.000 claims description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 210000002966 serum Anatomy 0.000 claims description 8
- 102000009027 Albumins Human genes 0.000 claims description 7
- 108010088751 Albumins Proteins 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 6
- 230000008878 coupling Effects 0.000 claims description 6
- 238000010168 coupling process Methods 0.000 claims description 6
- 238000005859 coupling reaction Methods 0.000 claims description 6
- 230000036039 immunity Effects 0.000 claims description 5
- 238000002203 pretreatment Methods 0.000 claims description 5
- FJWGRXKOBIVTFA-UHFFFAOYSA-N 2,3-dibromobutanedioic acid Chemical compound OC(=O)C(Br)C(Br)C(O)=O FJWGRXKOBIVTFA-UHFFFAOYSA-N 0.000 claims description 4
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 claims description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 150000008064 anhydrides Chemical class 0.000 claims description 4
- VANNPISTIUFMLH-UHFFFAOYSA-N glutaric anhydride Chemical compound O=C1CCCC(=O)O1 VANNPISTIUFMLH-UHFFFAOYSA-N 0.000 claims description 4
- 239000003550 marker Substances 0.000 claims description 4
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 238000013016 damping Methods 0.000 claims description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 3
- NFJCQBGAUBIGKV-UHFFFAOYSA-N nitro dihydrogen phosphate Chemical compound OP(O)(=O)O[N+]([O-])=O NFJCQBGAUBIGKV-UHFFFAOYSA-N 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 244000309466 calf Species 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract description 9
- 230000008569 process Effects 0.000 abstract description 6
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 230000006835 compression Effects 0.000 abstract 2
- 238000007906 compression Methods 0.000 abstract 2
- 238000007865 diluting Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 31
- 238000002835 absorbance Methods 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 238000004321 preservation Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 210000004408 hybridoma Anatomy 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 239000012488 sample solution Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 206010003445 Ascites Diseases 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 235000021336 beef liver Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 231100000703 Maximum Residue Limit Toxicity 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 2
- 239000005662 Paraffin oil Substances 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 2
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000005251 capillar electrophoresis Methods 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000005138 cryopreservation Methods 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000000749 insecticidal effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 241000283705 Capra hircus Species 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 238000003822 preparative gas chromatography Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ||
CV% | 01批 | 4.5 | 4.7 | 6.8 | 8.3 | 3.9 | 9.3 | 9.1 | 5.6 | 8.7 | 4.0 |
03批 | 5.8 | 4.2 | 6.1 | 6.8 | 6.3 | 7.4 | 5.9 | 8.2 | 5.3 | 6.9 | |
06批 | 6.8 | 4.8 | 8.5 | 7.3 | 6.7 | 4.1 | 9.4 | 5.6 | 7.5 | 4.9 |
批号 | 实测值(μg/kg) | 变异系数CV% | ||||
050600505060100507009 | 4.64.63.64.13.64.13.44.54.9 | 3.44.13.74.93.74.94.84.24.7 | 4.94.94.23.54.83.23.24.83.9 | 55.13.94.73.24.73.74.34.7 | 4.13.74.63.24.53.553.94.6 | 14.912.810.118.016.818.019.57.78.4 |
批号 | 实测值(μg/kg) | 变异系数CV% | ||||
0506005 | 3.43.6 | 4.64.7 | 5.14.2 | 4.95 | 3.73.2 | 17.218.0 |
05060100507009 | 4.63.73.63.63.63.23.6 | 3.73.14.63.83.73.84.6 | 4.13.44.13.14.24.23.8 | 4.64.64.94.24.64.94.1 | 3.44.93.24.64.84.54.2 | 13.119.717.114.812.715.89.4 |
样本 | 牛肉 | 牛肝 | |||
添加浓度(μg/kg) | 5 | 10 | 5 | 10 | |
回收率% | 1234 | 93.4108.483.786.4 | 97.287.3104.697.8 | 86.394.281.6108.4 | 83.276.597.468.1 |
平均值 | 92.9 | 96.7 | 92.6 | 81.3 |
药物名称 | 交叉反应率(%) |
阿维菌素 | 32.3 |
依维菌素 | 100.0 |
埃比菌素 | 134.8 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100867703A CN100501407C (zh) | 2005-11-03 | 2005-11-03 | 检测阿维菌素类药物的酶联免疫试剂盒及方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100867703A CN100501407C (zh) | 2005-11-03 | 2005-11-03 | 检测阿维菌素类药物的酶联免疫试剂盒及方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1766625A true CN1766625A (zh) | 2006-05-03 |
CN100501407C CN100501407C (zh) | 2009-06-17 |
Family
ID=36742629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100867703A Expired - Fee Related CN100501407C (zh) | 2005-11-03 | 2005-11-03 | 检测阿维菌素类药物的酶联免疫试剂盒及方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100501407C (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101813696A (zh) * | 2010-04-09 | 2010-08-25 | 镇江出入境检验检疫局检验检疫综合技术中心 | 动物源性食品中重氮氨苯脒免疫学快速检测方法 |
CN101021535B (zh) * | 2007-03-12 | 2011-06-22 | 北京望尔康泰生物技术有限公司 | 检测庆大霉素药物的酶联免疫试剂盒及方法 |
CN106771210A (zh) * | 2016-11-23 | 2017-05-31 | 百奥森(江苏)食品安全科技有限公司 | 一种食品中呕吐毒素的检测试剂盒 |
CN106770213A (zh) * | 2016-12-05 | 2017-05-31 | 百奥森(江苏)食品安全科技有限公司 | 一种伊维菌素检测方法及试剂盒 |
CN109180760A (zh) * | 2018-08-30 | 2019-01-11 | 华中农业大学 | 一种伊维菌素衍生物和抗阿维菌素类药物的单克隆抗体及其应用 |
CN109541216A (zh) * | 2018-10-26 | 2019-03-29 | 北京勤邦生物技术有限公司 | 检测伊维菌素和阿维菌素的酶联免疫试剂盒及其应用 |
CN112684177A (zh) * | 2020-12-17 | 2021-04-20 | 北京维德维康生物技术有限公司 | 一种乳品多因子快速检测试剂盒及其检测方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2039541A1 (en) * | 1990-04-05 | 1991-10-06 | Ethel B. Jacobson | Monoclonal antibodies to avermectins |
-
2005
- 2005-11-03 CN CNB2005100867703A patent/CN100501407C/zh not_active Expired - Fee Related
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101021535B (zh) * | 2007-03-12 | 2011-06-22 | 北京望尔康泰生物技术有限公司 | 检测庆大霉素药物的酶联免疫试剂盒及方法 |
CN101813696A (zh) * | 2010-04-09 | 2010-08-25 | 镇江出入境检验检疫局检验检疫综合技术中心 | 动物源性食品中重氮氨苯脒免疫学快速检测方法 |
CN106771210A (zh) * | 2016-11-23 | 2017-05-31 | 百奥森(江苏)食品安全科技有限公司 | 一种食品中呕吐毒素的检测试剂盒 |
CN106770213A (zh) * | 2016-12-05 | 2017-05-31 | 百奥森(江苏)食品安全科技有限公司 | 一种伊维菌素检测方法及试剂盒 |
CN109180760A (zh) * | 2018-08-30 | 2019-01-11 | 华中农业大学 | 一种伊维菌素衍生物和抗阿维菌素类药物的单克隆抗体及其应用 |
CN109180760B (zh) * | 2018-08-30 | 2021-09-17 | 华中农业大学 | 一种伊维菌素衍生物和抗阿维菌素类药物的单克隆抗体及其应用 |
CN109541216A (zh) * | 2018-10-26 | 2019-03-29 | 北京勤邦生物技术有限公司 | 检测伊维菌素和阿维菌素的酶联免疫试剂盒及其应用 |
CN109541216B (zh) * | 2018-10-26 | 2022-10-21 | 北京勤邦生物技术有限公司 | 检测伊维菌素和阿维菌素的酶联免疫试剂盒及其应用 |
CN112684177A (zh) * | 2020-12-17 | 2021-04-20 | 北京维德维康生物技术有限公司 | 一种乳品多因子快速检测试剂盒及其检测方法 |
CN112684177B (zh) * | 2020-12-17 | 2024-05-28 | 北京维德维康生物技术有限公司 | 一种乳品多因子快速检测试剂盒及其检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100501407C (zh) | 2009-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100403030C (zh) | 检测苏丹红药物的酶联免疫试剂盒及方法 | |
CN100344971C (zh) | 一种检测动物源性食品中磺胺类药物残留的酶联免疫试剂盒 | |
CN1766625A (zh) | 检测阿维菌素类药物的酶联免疫试剂盒及方法 | |
CN1766630A (zh) | 一种检测动物源性食品中莱克多巴胺的酶联免疫试剂盒 | |
CN1766617A (zh) | 检测β-兴奋剂类药物的酶联免疫试剂盒及其方法 | |
CN1766629A (zh) | 一种检测动物源性食品中氯霉素类药物的酶联免疫试剂盒 | |
CN1811443A (zh) | 一种检测19-去甲睾酮的方法及其专用酶联免疫试剂盒 | |
CN1811436A (zh) | 一种检测恩诺沙星的方法及其专用酶联免疫试剂盒 | |
CN101046474A (zh) | 一种检测喹噁啉类药物残留的酶联免疫试剂盒 | |
CN103630689B (zh) | 一种检测西马特罗药物残留的酶联免疫试剂盒及其制备方法与应用 | |
CN101021535B (zh) | 检测庆大霉素药物的酶联免疫试剂盒及方法 | |
CN1811437A (zh) | 一种检测磺胺喹噁啉的方法及其专用酶联免疫试剂盒 | |
CN1766618A (zh) | 检测青霉素g的酶联免疫试剂盒及其方法 | |
CN1811440A (zh) | 一种检测伊维菌素的方法及其专用酶联免疫试剂盒 | |
CN1811442A (zh) | 一种检测泰乐菌素的方法及其专用酶联免疫试剂盒 | |
CN1262839C (zh) | 一种检测磺胺二甲嘧啶的酶联免疫试剂盒 | |
CN103364553B (zh) | 检测硝基咪唑类药物的酶联免疫试剂盒及其应用 | |
CN1766633A (zh) | 检测已烯雌酚残留的酶联免疫试剂盒及方法 | |
CN1766632A (zh) | 一种检测动物源性食品中氟喹酮类药物的酶联免疫试剂盒 | |
CN101915845A (zh) | 一种检测莱克多巴胺的方法及其专用化学发光免疫试剂盒 | |
CN110133306A (zh) | 检测西马特罗的酶联免疫试剂盒及其应用 | |
CN1766628A (zh) | 检测安定残留的酶联免疫试剂盒及方法 | |
CN1766626A (zh) | 检测雌二醇的酶联免疫试剂盒及方法 | |
CN1844927A (zh) | 检测氟甲喹药物的酶联免疫试剂盒及方法 | |
CN1811441A (zh) | 一种检测盐霉素的方法及其专用酶联免疫试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Effective date of registration: 20091009 Pledge (preservation): Pledge |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20100901 Granted publication date: 20090617 Pledgee: Zhongguancun Beijing science and technology Company limited by guarantee Pledgor: Beijing Wanger Biotechnology Co.,Ltd. Registration number: 2009110000623 |
|
ASS | Succession or assignment of patent right |
Owner name: GUIZHOU QINBANG FOOD SAFETY SCIENCE AND TECHNOLOGY Free format text: FORMER OWNER: BEIJING WANGER BIOTECHNOLOGY CO., LTD. Effective date: 20130717 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100094 HAIDIAN, BEIJING TO: 550009 GUIYANG, GUIZHOU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130717 Address after: 550009, Guizhou province Guiyang Xiaohe Industrial Park standard factory building No. two, building 1, building 1-2 Patentee after: GUIZHOU KWINBON SCIENCE AND TECHNOLOGY FOR FOOD SAFETY Co.,Ltd. Address before: 100094 national veterinary drug safety evaluation center, West School of veterinary medicine, China Agricultural University, 2 West Old Summer Palace Road, Beijing, Haidian District Patentee before: Beijing Wanger Biotechnology Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090617 Termination date: 20211103 |